James Baumgartner, MD: Clinical Trials

3 trials sponsored by James Baumgartner, MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 suspended, 1 withdrawn. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Suspended 1, Withdrawn 1
Phase 22Suspended 1, Withdrawn 1

Follow James Baumgartner, MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss
Autologous Bone Marrow Infusion - Sensorineural Hearing Loss
Phase 1 / Phase 2SuspendedJames Baumgartner, MD102015-10-012022-03-18
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke
Autologous Cord Blood Infusion - Perinatal Arterial Ischemic Stroke
Phase 1 / Phase 2WithdrawnJames Baumgartner, MD2015-04-012026-06-16
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
Autologous Stem Cells - Sensorineural Hearing Loss
Phase 1CompletedJames Baumgartner, MD112013-01-012026-07-09

Conditions studied

Hearing Loss, Sensorineural (2)

Interventions

Cell- and Tissue-Based Therapy (2)

Countries

United States (3)